Frankfurt - Delayed Quote EUR
Ascendis Pharma A/S (A71.F)
144.00
-5.00
(-3.36%)
As of 8:00:44 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
--
-306.20M
-467.36M
-495.70M
-417.65M
Investing Cash Flow
--
6.88M
286.47M
61.73M
-110.58M
Financing Cash Flow
--
443.93M
134.29M
396.77M
351.39M
End Cash Position
--
559.54M
392.16M
444.77M
446.27M
Capital Expenditure
--
-1.43M
-2.44M
-14.49M
-24.23M
Issuance of Capital Stock
--
309.91M
0.00
0.00
367.88M
Issuance of Debt
--
134.16M
136.26M
503.28M
0.00
Repayment of Debt
--
-11.37M
-10.44M
-6.36M
-6.43M
Repurchase of Capital Stock
--
0.00
0.00
-105.31M
-21.61M
Free Cash Flow
--
-307.62M
-469.80M
-510.19M
-441.88M
12/31/2021 - 2/2/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade